Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Velocity One Signs Merger Agreement With EMCORE (EMKR)
-
NioCorp Provides Preliminary Financial Results for the Three Months Ended September 30, 2024
-
Honey Badger Announces Change of Transfer Agent
-
Bedford Park Opportunities Fund Wins First Place at the 2024 Canadian Hedge Fund Awards with a return of 73.6%
-
Kiora Pharmaceuticals Reports Third Quarter Results; Retinal Disease Pipeline Advancing Two Phase 2 Studies
-
Prospect Capital Announces Financial Results for Fiscal September 2024 Quarter
-
Neptune Software to Participate in 2024 ASUG TechConnect Event
-
NuVista Energy Ltd. Announces Strong Third Quarter 2024 Financial and Operating Results, LNG Agreement, 2025 Budget, and Enhanced Shareholder Return Strategy
-
Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024
-
Nexans to sell AmerCable to Mattr
-
Calumet Reports Third Quarter 2024 Results
-
Onex Reports Third Quarter 2024 Results
-
Main Street Duncan Gearing Up for Annual Holiday Stroll on November 16th
-
Canopy Growth Reports Second Quarter Fiscal Year 2025 Financial Results
-
Novel Microdevices, Inc. Announces ~$2.7M Follow on Funding from NIH RADx® Tech
-
HORIZON PETROLEUM ANNOUNCES CONDITIONAL APPROVAL FOR REINSTATEMENT ONTO THE TSX VENTURE EXCHANGE AND CLOSING OF THE SECOND TRANCHE OF FINANCING
-
Seer to Participate in Upcoming November Investor Conferences
-
MADISON SQUARE GARDEN ENTERTAINMENT CORP. REPORTS FISCAL 2025 FIRST QUARTER RESULTS
-
2nd Annual 2025 KEDO Nations Cup to Kick Off in Charlotte, NC, Raising Funds for Health Clinic in Liberia
-
Samsung Biologics earns ISO certifications in recognition of business excellence
-
Jensen Hughes Appoints Dominic Casserley as Executive Chair of the Board of Directors
-
Ultralife Corporation Reports Third Quarter Results
-
FLOWERS FOODS, INC. REPORTS THIRD QUARTER 2024 RESULTS
-
TEXAS HUMANE LEGISLATION NETWORK HONORS FARMHOUSE FRESH SKINCARE AS 2024 HUMANE HERO AWARD RECIPIENT
-
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO® / DARZALEX® as subcutaneous monotherapy for high-risk smoldering multiple myeloma
-
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
-
Bloomin’ Brands Announces 2024 Q3 Financial Results
-
Velocity One Signs Merger Agreement with EMCORE (EMKR)
-
SystImmune, Inc. Announces FDA Clearance of IND Application for BL-M17D1 in Advanced Solid Tumors
-
Xeris Biopharma Reports Third Quarter 2024 Financial Results
-
United Homes Group, Inc. Reports 2024 Third Quarter Results
-
Neurotech Provides Update on BLA for NT-501 as a Treatment for Macular Telangiectasia Type 2 (MacTel)
-
Ferraro Foods Partners with Pepper to Launch Mobile-Based Ordering App
-
Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results
-
Kontrol Technologies Announces $2 Million Bitcoin Purchase Plan and Expanding with Data Center Customers
-
Glaukos Announces Participation in Upcoming Investor Conferences
-
Softchoice Announces Third Quarter 2024 Results
-
Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook
-
TEZSPIRE met both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps
-
Clay Cooley Auto Group Expands in Arlington with Acquisition of Don Davis Nissan
-
Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference
-
Pound Sterling Conversion Rate for 2024 Interim Dividend
-
Hippo Reports Third Quarter 2024 Financial Results
-
The international jury of experts for the ninth edition of the Ernesto Illy International Coffee Award has been announced
-
Paying with Crypto Goes Mainstream
-
Assured Guaranty Ltd. Declares Quarterly Dividend of $0.31 per Common Share
-
FDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer
-
Paramount Global Reports Third Quarter Earnings Results
-
Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
-
1stDibs Reports Third Quarter 2024 Financial Results
